$SMMT News and Market Events
Every $SMMT story Market Flux has tracked.
- Last 7 days
- 3 stories
- Previous 7 days
- 0 stories
- Latest story
- Related topics
- Healthcare
- Market Flux Event
Sellas Life Sciences Surges 156% After Cancer Vaccine Cuts Death Risk by 41% in Late-Stage Trial
Sellas Life Sciences shares surged 156% after the New York-based drugmaker reported positive pivotal Phase 3 data for its experimental cancer vaccine galinpepimut-S in acute myeloid…
- Unusual Volume
FDA Rejects Summit Therapeutics Ivonescimab BLA, Citing Lack of Overall Survival Data
The U.S. Food and Drug Administration issued a Complete Response Letter on November 15, 2026, refusing to approve Summit Therapeutics' Biologics License Application for ivonescimab in…
- Market Flux Event
FDA Rejects Summit Therapeutics Ivonescimab for Lung Cancer, Demands Overall Survival Data
The U.S. Food and Drug Administration issued a Complete Response Letter on November 15, 2026, refusing to approve Summit Therapeutics' Biologics License Application for ivonescimab, a novel…